Glenmark Pharmaceuticals rises with arm launching generic version of Zetia in US

13 Dec 2016 Evaluate

Glenmark Pharmaceuticals is currently trading at Rs. 916.00, up by 3.40 points or 0.37% from its previous closing of Rs. 912.60 on the BSE.

The scrip opened at Rs. 932.00 and has touched a high and low of Rs. 935.00 and Rs. 916.00 respectively. So far 6,289 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 993.00 on 01-Nov-2016 and a 52 week low of Rs. 671.50 on 12-Feb-2016.

Last one week high and low of the scrip stood at Rs. 954.00 and Rs. 863.00 respectively. The current market cap of the company is Rs. 25,894.57 crore.

The promoters holding in the company stood at 46.49%, while Institutions and Non-Institutions held 41.61% and 11.91% respectively.

Glenmark Pharmaceuticals’ arm - Glenmark Pharmaceuticals Inc., USA, has announced the availability of ezetimibe, the first and only generic version of Zetia (Merck) in the United States for the treatment of high cholesterol. The availability of ezetimibe is the result of a licensing partnership with Par Pharmaceutical, an Endo International plc operating company, with whom Glenmark will share profits.

Glenmark and its partner, Endo will be entitled to 180 days of generic drug exclusivity for ezetimibe as provided for under FD&C Act. According to IMS Health data for the 12-month period ending October 2016, annual US sales of Zetia 10 mg were approximately $2.3 billion.

Ezetimibe is indicated as adjunctive therapy to diet for the reduction of elevated total cholesterol (total-C), low-density lipoprotein cholesterol (LDL-C), and apolipoprotein B (Apo B) in patients with primary (heterozygous familial and non-familial) hyperlipidemia.


Glenmark Pharma Share Price

1965.75 -8.40 (-0.43%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×